[关键词]
[摘要]
眼底新生血管性疾病是指因脉络膜及视网膜组织内病理性血管异常增殖而引发一系列临床病理改变的一类疾病,是导致眼底组织损伤及视力严重受损的主要病因之一。近年来,免疫炎症反应已被证实为驱动新生血管形成的关键环节; 其中,调节性T细胞(Treg)作为一类具有免疫负调控功能的T细胞亚群及维持免疫稳态的核心调控者,其在眼底新生血管发生发展中的作用日益凸显,已成为该领域的研究热点。文章系统综述Treg通过调控眼部免疫微环境介导血管生成的核心作用机制,阐释其在不同疾病背景及病程阶段中的背景依赖性双重效应,梳理靶向 Treg 的前沿治疗策略,旨在为该类疾病的机制研究与临床诊疗转化提供前瞻性参考。
[Key word]
[Abstract]
Neovascular diseases of the fundus are a group of disorders caused by pathological abnormal proliferation of blood vessels in the choroid and retina, which induces a series of clinical pathological changes and represents one of the major causes of fundus tissue damage and severe visual impairment. In recent years, immune-inflammatory responses have been confirmed as a key driver of neovascularization. As a T cell subset with negative immune regulatory functions and a core regulator for maintaining immune homeostasis, regulatory T cells(Tregs)play an increasingly prominent role in the initiation and progression of fundus neovascularization and have become a research hotspot in this field. This review systematically summarizes the core mechanisms by which Tregs mediate angiogenesis via modulation of the ocular immune microenvironment, illustrates their context-dependent dual effects under different disease conditions and at various disease stages, and outlines cutting-edge Treg-targeted therapeutic strategies. It aims to provide forward-looking references for mechanistic research and translational clinical diagnosis and treatment of such diseases.
[中图分类号]
[基金项目]